title: Continuous ambulatory peritoneal dialysis and the heart.
abstract: OBJECTIVE
  To review clinical research pertaining to continuous ambulatory peritoneal dialysis (CAPD) and the heart.
  
  
  METHODS
  A Medline computer search was employed to identify appropriate references from 1970 - 1994. Indexing terms were: continuous ambulatory peritoneal dialysis, hemodialysis, heart or cardiac, left ventricle, coronary artery disease, and survival. English and non-English language abstracts were scrutinized.
  
  
  METHODS
  Forty-six studies were reviewed and utilized. Numerical data extracted are reported in this review as they were reported in the original article.
  
  
  RESULTS
  This review provides a broad-based survey of studies pertaining to CAPD and the heart. Most of the studies relate to CAPD and left ventricular structure or function. Little information exists concerning CAPD and coronary artery disease, valvular disease, pericardial disease, and cardiac arrhythmias. Studies pertaining to patient survival on CAPD identify coronary artery disease and congestive heart failure as major risk factors, but in-depth quantification of these cardiovascular disorders is lacking in the literature.
  
  
  CONCLUSIONS
  CAPD is capable of decreasing left ventricular (LV) volume and improving LV systolic function in patients with LV enlargement and those with LV systolic dysfunction. The effect of CAPD on left ventricular hypertrophy (LVH) and LV diastolic function is variable. CAPD produces symptomatic improvement in patients with refractory congestive heart failure, but its effect on survival in such patients is uncertain. Atherogenic lipid abnormalities occur in CAPD patients. The clinical significance of these abnormalities is uncertain. Coronary artery bypass surgery can be performed safely and effectively on CAPD patients. CAPD is not arrhythmogenic. Survival of CAPD patients is similar to that of hemodialysis patients except in elderly diabetics for whom it is slightly lower.
authors.affiliation: Department of Internal Medicine, University of South Alabama, Mobile, U.S.A.
authors.forename: M A
authors.initials: MA
authors.lastname: Alpert
authors.forename: J
authors.initials: J
authors.lastname: Hüting
authors.forename: Z J
authors.initials: ZJ
authors.lastname: Twardowski
authors.forename: R
authors.initials: R
authors.lastname: Khanna
authors.forename: K D
authors.initials: KD
authors.lastname: Nolph
mesh_terms: D001145:Arrhythmias, Cardiac; D006348:Cardiac Surgical Procedures; D002317:Cardiovascular Agents; D003327:Coronary Disease; D006331:Heart Diseases; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy*; D010531:Peritoneal Dialysis, Continuous Ambulatory; D016277:Ventricular Function, Left
chemical_list: D002317:Cardiovascular Agents